Lessons from nature: "Pathogen-Mimetic" systems for mucosal Nano-medicines

Advanced Drug Delivery Reviews

Volumn 61, Issue 2, 2009, Pages 172-192

  Mrsny, Randall J ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Bacterial toxin; Delivery; Protein therapeutics; Transcytosis

Indexed keywords

BACTERIAL TOXIN; BIO ACTIVE MATERIALS; BIOLOGICALLY ACTIVE MATERIALS; DELIVERY; EXTERNAL ENVIRONMENTS; GASTRO-INTESTINAL TRACTS; MUCOSAL SURFACES; NANO-SCALE; PATHOGENIC BACTERIA; PHARMACEUTICAL AGENTS; PROTECTIVE BARRIERS; PROTEIN THERAPEUTICS; THERAPEUTIC SYSTEMS; TRANSCYTOSIS; VIRULENCE FACTORS;

BACTERIA; BACTERIOLOGY; LIGANDS; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY;

SURFACES;

BACTERIAL TOXIN; NANOPARTICLE;

BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL ADHESION; CELL INTERACTION; CELL POLARITY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; EPITHELIUM CELL; HOST CELL; HUMAN; MUCUS; MUCUS SECRETION; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ENGINEERING; REVIEW;

ANIMALS; BACTERIAL ADHESION; BIOMIMETICS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MACROMOLECULAR SUBSTANCES; MUCOUS MEMBRANE; MUCUS; NANOMEDICINE; NANOPARTICLES;

EID: 60149088354     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.09.009     Document Type: Review

References (191)

1. Coulman S., Allender C., and Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit. Rev. Ther. Drug Carr. Syst. 23 (2006) 205-258
2. Utech M., Bruwer M., and Nusrat A. Tight junctions and cell-cell interactions. Methods Mol. Biol. 341 (2006) 185-195
3. Mullin J.M., Agostino N., Rendon-Huerta E., and Thornton J.J. Keynote review: epithelial and endothelial barriers in human disease. Drug Discov. Today 10 (2005) 395-408
4. Mostov K., Su T., and ter Beest M. Polarized epithelial membrane traffic: conservation and plasticity. Nat. Cell Biol. 5 (2003) 287-293
5. Joiner K.A. Membrane-protein traffic in pathogen-infected cells. J. Clin. Invest. 99 (1997) 1814-1817
6. Daugherty A.L., and Mrsny R.J. Transcellular uptake mechanisms of the intestinal epithelial barrier Part one. Pharm. Sci. Technol. Today 4 (1999) 144-151
7. Langoth N., Bernkop-Schnurch A., and Kurka P. In vitro evaluation of various buccal permeation enhancing systems for PACAP (pituitary adenylate cyclase-activating polypeptide). Pharm. Res. 22 (2005) 2045-2050
8. Senel S., Kremer M., Nagy K., and Squier C. Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr. Pharm. Biotechnol. 2 (2001) 175-186
9. van Eyk A.D., and van der Bijl P. Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa. Arch. Oral Biol. 49 (2004) 387-392
10. Vishnu Y.V., Chandrasekhar K., Ramesh G., and Rao Y.M. Development of mucoadhesive patches for buccal administration of carvedilol. Curr. Drug Deliv. 4 (2007) 27-39
11. Starokadomskyy P.L., and Dubey I.Y. New absorption promoter for the buccal delivery: preparation and characterization of lysalbinic acid. Int. J. Pharm. 308 (2006) 149-154
12. Blaser M.J. Ecology of Helicobacter pylori in the human stomach. J. Clin. Invest. 100 (1997) 759-762
13. Ha U., Lim J.H., Jono H., Koga T., Srivastava A., Malley R., Pages G., Pouyssegur J., and Li J.D. A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J. Immunol. 178 (2007) 1736-1747
14. Chan H.K. Dry powder aerosol delivery systems: current and future research directions. J. Aerosol Med. 19 (2006) 21-27
15. Langoth N., Kahlbacher H., Schoffmann G., Schmerold I., Schuh M., Franz S., Kurka P., and Bernkop-Schnurch A. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. Pharm. Res. 23 (2006) 573-579
16. Pedersen A.M., Bardow A., Jensen S.B., and Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis. 8 (2002) 117-129
17. Russell T.L., Berardi R.R., Barnett J.L., Dermentzoglou L.C., Jarvenpaa K.M., Schmaltz S.P., and Dressman J.B. Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women. Pharm. Res. 10 (1993) 187-196
18. Kaniwa N., Aoyagi N., Ogata H., and Ejima A. Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates. J. Pharmacobio-dyn. 11 (1988) 563-570
19. Kaniwa N., Aoyagi N., Ogata H., Ejima A., Motoyama H., and Yasumi H. Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans. J. Pharmacobio-dyn. 11 (1988) 571-575
20. Malbert C.H., and Ruckebusch Y. Duodenal bulb control of the flow rate of digesta in the fasted and fed dog. J. Physiol. 409 (1989) 371-384
21. Schulze K. Imaging and modelling of digestion in the stomach and the duodenum. Neurogastroenterol. Motil. 18 (2006) 172-183
22. Parkman H.P., Urbain J.L., Knight L.C., Brown K.L., Trate D.M., Miller M.A., Maurer A.H., and Fisher R.S. Effect of gastric acid suppressants on human gastric motility. Gut 42 (1998) 243-250
23. Brannon P.M. Adaptation of the exocrine pancreas to diet. Annu. Rev. Nutr. 10 (1990) 85-105
24. Czako L., Hajnal F., Nemeth J., Takacs T., and Lonovics J. Effect of a liquid meal given as a bolus into the jejunum on human pancreatic secretion. Pancreas 18 (1999) 197-202
25. Woods C.M., Mawe G.M., Toouli J., and Saccone G.T. The sphincter of Oddi: understanding its control and function. Neurogastroenterol. Motil. 17 Suppl 1 (2005) 31-40
26. Rao S.S., Lu C., and Schulze-Delrieu K. Duodenum as a immediate brake to gastric outflow: a videofluoroscopic and manometric assessment. Gastroenterology 110 (1996) 740-747
27. Castedal M., Bjornsson E., and Abrahamsson H. Postprandial peristalsis in the human duodenum. Neurogastroenterol. Motil. 10 (1998) 227-233
28. Bennink R., Peeters M., Van den Maegdenbergh V., Geypens B., Rutgeerts P., De Roo M., and Mortelmans L. Evaluation of small-bowel transit for solid and liquid test meal in healthy men and women. Eur. J. Nucl. Med. 26 (1999) 1560-1566
29. Schneider A.R., Jepp K., Murczynski L., Biniek U., and Stein J. The inulin hydrogen breath test accurately reflects orocaecal transit time. Eur. J. Clin. Invest. 37 (2007) 802-807
30. Mojaverian P., Chan K., Desai A., and John V. Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy. Pharm. Res. 6 (1989) 719-724
31. Pelot D., and Grossman M.I. Distribution and fate of pancreatic enzymes in small intestine of the rat. Am. J. Physiol. 202 (1962) 285-288
32. Fallingborg J., Christensen L.A., Ingeman-Nielsen M., Jacobsen B.A., Abildgaard K., Rasmussen H.H., and Rasmussen S.N. Measurement of gastrointestinal pH and regional transit times in normal children. J. Pediatr. Gastroenterol. Nutr. 11 (1990) 211-214
33. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., and Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006) 1027-1031
34. Friend D.R. New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. 57 (2005) 247-265
35. McInnes F.J., O'Mahony B., Lindsay B., Band J., Wilson C.G., Hodges L.A., and Stevens H.N. Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy. Eur. J. Pharm. Sci. 31 (2007) 25-31
36. Kimbell J.S., Overton J.H., Subramaniam R.P., Schlosser P.M., Morgan K.T., Conolly R.B., and Miller F.J. Dosimetry modeling of inhaled formaldehyde: binning nasal flux predictions for quantitative risk assessment. Toxicol. Sci. 64 (2001) 111-121
37. Costantino H.R., Illum L., Brandt G., Johnson P.H., and Quay S.C. Intranasal delivery: physicochemical and therapeutic aspects. Int. J. Pharm. 337 (2007) 1-24
38. Laube B.L. In vivo measurements of aerosol dose and distribution: clinical relevance. J. Aerosol Med. 9 Suppl 1 (1996) S77-S91
39. Chilvers M.A., and O'Callaghan C. Local mucociliary defence mechanisms. Paediatr. Respir. Rev. 1 (2000) 27-34
40. Patton J.S., McCabe J.G., Hansen S.E., and Daugherty A.L. Absorption of human growth hormone from the rat lung. Biotechnol. Ther. 1 (1989) 213-228
41. Patton J.S., Fishburn C.S., and Weers J.G. The lungs as a portal of entry for systemic drug delivery. Proc. Am. Thorac. Soc. 1 (2004) 338-344
42. Gonda I. Systemic delivery of drugs to humans via inhalation. J. Aerosol Med. 19 (2006) 47-53
43. Sherwood J.K., Zeitlin L., Whaley K.J., Cone R.A., and Saltzman M. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes. Nat. Biotechnol. 14 (1996) 468-471
44. Kraehenbuhl J.P., and Neutra M.R. Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol. 16 (2000) 301-332
45. Cossart P., and Sansonetti P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304 (2004) 242-248
46. Mrsny R.J., Gewirtz A.T., Siccardi D., Savidge T., Hurley B.P., Madara J.L., and McCormick B.A. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7421-7426
47. Didierlaurent A., Sirard J.C., Kraehenbuhl J.P., and Neutra M.R. How the gut senses its content. Cell. Microbiol. 4 (2002) 61-72
48. Andersen C. Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria. Rev. Physiol., Biochem. Pharmacol. 147 (2003) 122-165
49. Johnson T.L., Abendroth J., Hol W.G., and Sandkvist M. Type II secretion: from structure to function. FEMS Microbiol. Lett. 255 (2006) 175-186
50. Ly K.T., and Casanova J.E. Mechanisms of Salmonella entry into host cells. Cell. Microbiol. 9 (2007) 2103-2111
51. Backert S., and Meyer T.F. Type IV secretion systems and their effectors in bacterial pathogenesis. Curr. Opin. Microbiol. 9 (2006) 207-217
52. Li J., Wolf S.G., Elbaum M., and Tzfira T. Exploring cargo transport mechanics in the type IV secretion systems. Trends Microbiol. 13 (2005) 295-298
53. Collins R.F., Frye S.A., Kitmitto A., Ford R.C., Tonjum T., and Derrick J.P. Structure of the Neisseria meningitidis outer membrane PilQ secretin complex at 12 A resolution. J. Biol. Chem. 279 (2004) 39750-39756
54. Clyne M., Dolan B., and Reeves E.P. Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori. FEMS Microbiol. Lett. 268 (2007) 135-143
55. Kerr J.R., and Matthews R.C. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 77-88
56. Salyers A.A., and Whitt D.D. Bacterial Pathogenesis: A Molecular Approach (2002), ASM Press, Washington, D.C.
57. Mougous J.D., Cuff M.E., Raunser S., Shen A., Zhou M., Gifford C.A., Goodman A.L., Joachimiak G., Ordonez C.L., Lory S., Walz T., Joachimiak A., and Mekalanos J.J. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312 (2006) 1526-1530
58. Pukatzki S., Ma A.T., Sturtevant D., Krastins B., Sarracino D., Nelson W.C., Heidelberg J.F., and Mekalanos J.J. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1528-1533
59. Kuehn M.J., and Kesty N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19 (2005) 2645-2655
60. McBroom A.J., and Kuehn M.J. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol. Microbiol. 63 (2007) 545-558
61. Gill D.B., Spitzer D., Koomey M., Heuser J.E., and Atkinson J.P. Release of host-derived membrane vesicles following pilus-mediated adhesion of Neisseria gonorrhoeae. Cell. Microbiol. 7 (2005) 1672-1683
62. Sibbald M.J., Ziebandt A.K., Engelmann S., Hecker M., de Jong A., Harmsen H.J., Raangs G.C., Stokroos I., Arends J.P., Dubois J.Y., and van Dijl J.M. Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol. Mol. Biol. Rev. 70 (2006) 755-788
63. Alverdy J., Holbrook C., Rocha F., Seiden L., Wu R.L., Musch M., Chang E., Ohman D., and Suh S. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann. Surg. 232 (2000) 480-489
64. Soong G., Muir A., Gomez M.I., Waks J., Reddy B., Planet P., Singh P.K., Kaneko Y., Wolfgang M.C., Hsiao Y.S., Tong L., and Prince A. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin. Invest. 116 (2006) 2297-2305
65. Erdem A.L., Avelino F., Cortes J.X., and Giron J.A. Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. J. Bacteriol. 189 (2007) 7426-7435
66. Barocchi M.A., Ries J., Zogaj X., Hemsley C., Albiger B., Kanth A., Dahlberg S., Fernebro J., Moschioni M., Masignani V., Hultenby K., Taddei A.R., Beiter K., Wartha F., von Euler A., Covacci A., Holden D.W., Normark S., Rappuoli R., and Henriques-Normark B. A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2857-2862
67. Sauer F.G., Barnhart M., Choudhury D., Knight S.D., Waksman G., and Hultgren S.J. Chaperone-assisted pilus assembly and bacterial attachment. Curr. Opin. Struct. Biol. 10 (2000) 548-556
68. Saiman L., and Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92 (1993) 1875-1880
69. Lund B., Lindberg F., Marklund B.I., and Normark S. The PapG protein is the alpha-d-galactopyranosyl-(1--4)-beta-d-galactopyranose-binding adhesin of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 5898-5902
70. Bierne H., and Cossart P. Listeria monocytogenes surface proteins: from genome predictions to function. Microbiol. Mol. Biol. Rev. 71 (2007) 377-397
71. Preston A. Bordetella pertussis: the intersection of genomics and pathobiology. Cmaj 173 (2005) 55-62
72. Wooldridge K.G., and Ketley J.M. Campylobacter-host cell interactions. Trends Microbiol. 5 (1997) 96-102
73. Krogfelt K.A., Bergmans H., and Klemm P. Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect. Immun. 58 (1990) 1995-1998
74. Eto D.S., Jones T.A., Sundsbak J.L., and Mulvey M.A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 3 (2007) e100
75. Menozzi F.D., Mutombo R., Renauld G., Gantiez C., Hannah J.H., Leininger E., Brennan M.J., and Locht C. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect. Immun. 62 (1994) 769-778
76. Orndorff P.E., Devapali A., Palestrant S., Wyse A., Everett M.L., Bollinger R.R., and Parker W. Immunoglobulin-mediated agglutination of and biofilm formation by Escherichia coli K-12 require the type 1 pilus fiber. Infect. Immun. 72 (2004) 1929-1938
77. Ayala P., Wilbur J.S., Wetzler L.M., Tainer J.A., Snyder A., and So M. The pilus and porin of Neisseria gonorrhoeae cooperatively induce Ca(2+) transients in infected epithelial cells. Cell. Microbiol. 7 (2005) 1736-1748
78. Baorto D.M., Gao Z., Malaviya R., Dustin M.L., van der Merwe A., Lublin D.M., and Abraham S.N. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 389 (1997) 636-639
79. Lopez-Boado Y.S., Wilson C.L., and Parks W.C. Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin. J. Biol. Chem. 276 (2001) 41417-41423
80. Ciacci-Woolwine F., McDermott P.F., and Mizel S.B. Induction of cytokine synthesis by flagella from gram-negative bacteria may be dependent on the activation or differentiation state of human monocytes. Infect. Immun. 67 (1999) 5176-5185
81. Venkatesan M., Buysse J.M., Vandendries E., and Kopecko D.J. Development and testing of invasion-associated DNA probes for detection of Shigella spp. and enteroinvasive Escherichia coli. J. Clin. Microbiol. 26 (1988) 261-266
82. Brandal L.T., Lindstedt B.A., Aas L., Stavnes T.L., Lassen J., and Kapperud G. Octaplex PCR and fluorescence-based capillary electrophoresis for identification of human diarrheagenic Escherichia coli and Shigella spp. J. Microbiol. Methods 68 (2007) 331-341
83. Niemann H.H., Schubert W.D., and Heinz D.W. Adhesins and invasins of pathogenic bacteria: a structural view. Microbes Infect. 6 (2004) 101-112
84. Plant L., and Jonsson A.B. Contacting the host: insights and implications of pathogenic Neisseria cell interactions. Scand. J. Infect. Dis. 35 (2003) 608-613
85. Molinari G., Talay S.R., Valentin-Weigand P., Rohde M., and Chhatwal G.S. The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect. Immun. 65 (1997) 1357-1363
86. Talay S.R., Valentin-Weigand P., Jerlstrom P.G., Timmis K.N., and Chhatwal G.S. Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect. Immun. 60 (1992) 3837-3844
87. Smith A.M., Guzman C.A., and Walker M.J. The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol. Rev. 25 (2001) 309-333
88. Leininger E., Roberts M., Kenimer J.G., Charles I.G., Fairweather N., Novotny P., and Brennan M.J. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 345-349
89. Relman D.A., Domenighini M., Tuomanen E., Rappuoli R., and Falkow S. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2637-2641
90. Hannah J.H., Menozzi F.D., Renauld G., Locht C., and Brennan M.J. Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect. Immun. 62 (1994) 5010-5019
91. Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections. Curr. Opin. Gastroenterol. 22 (2006) 95-101
92. Lee D.G., Urbach J.M., Wu G., Liberati N.T., Feinbaum R.L., Miyata S., Diggins L.T., He J., Saucier M., Deziel E., Friedman L., Li L., Grills G., Montgomery K., Kucherlapati R., Rahme L.G., and Ausubel F.M. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 7 (2006) R90
93. Stover C.K., Pham X.Q., Erwin A.L., Mizoguchi S.D., Warrener P., Hickey M.J., Brinkman F.S., Hufnagle W.O., Kowalik D.J., Lagrou M., Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y., Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R., Smith K., Spencer D., Wong G.K., Wu Z., Paulsen I.T., Reizer J., Saier M.H., Hancock R.E., Lory S., and Olson M.V. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406 (2000) 959-964
94. Li Z., Kosorok M.R., Farrell P.M., Laxova A., West S.E., Green C.G., Collins J., Rock M.J., and Splaingard M.L. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. Jama 293 (2005) 581-588
95. Mrsny R.J., Daugherty A.L., McKee M.L., and FitzGerald D.J. Bacterial toxins as tools for mucosal vaccination. Drug Discov. Today 7 (2002) 247-258
96. Daugherty A.L., McKee M.L., FitzGerald D.J., and Mrsny R.J. Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node. J. Control. Release 65 (2000) 297-302
97. Mrsny R.J., Lazazzera B.A., Daugherty A.L., Schiller N.L., and Patapoff T.W. Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity. Pulm. Pharmacol. 7 (1994) 357-366
98. Mattoo S., Lee Y.M., and Dixon J.E. Interactions of bacterial effector proteins with host proteins. Curr. Opin. Immunol. 19 (2007) 392-401
99. Paulsen I.T., Banerjei L., Myers G.S., Nelson K.E., Seshadri R., Read T.D., Fouts D.E., Eisen J.A., Gill S.R., Heidelberg J.F., Tettelin H., Dodson R.J., Umayam L., Brinkac L., Beanan M., Daugherty S., DeBoy R.T., Durkin S., Kolonay J., Madupu R., Nelson W., Vamathevan J., Tran B., Upton J., Hansen T., Shetty J., Khouri H., Utterback T., Radune D., Ketchum K.A., Dougherty B.A., and Fraser C.M. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299 (2003) 2071-2074
100. Kong K.F., Vuong C., and Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int. J. Med. Microbiol. 296 (2006) 133-139
101. Savoia D., and Zucca M. Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr. Microbiol. 54 (2007) 440-444
102. Finlay B.B., and Cossart P. Exploitation of mammalian host cell functions by bacterial pathogens. Science 276 (1997) 718-725
103. Virji M., Makepeace K., Ferguson D.J., Achtman M., and Moxon E.R. Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol. Microbiol. 10 (1993) 499-510
104. Isberg R.R., and Leong J.M. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 60 (1990) 861-871
105. Young G.M., Badger J.L., and Miller V.L. Motility is required to initiate host cell invasion by Yersinia enterocolitica. Infect. Immun. 68 (2000) 4323-4326
106. Parkhill J., Wren B.W., Mungall K., Ketley J.M., Churcher C., Basham D., Chillingworth T., Davies R.M., Feltwell T., Holroyd S., Jagels K., Karlyshev A.V., Moule S., Pallen M.J., Penn C.W., Quail M.A., Rajandream M.A., Rutherford K.M., van Vliet A.H., Whitehead S., and Barrell B.G. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403 (2000) 665-668
107. Dziewanowska K., Patti J.M., Deobald C.F., Bayles K.W., Trumble W.R., and Bohach G.A. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect. Immun. 67 (1999) 4673-4678
108. Jonquieres R., Pizarro-Cerda J., and Cossart P. Synergy between the N- and C-terminal domains of InlB for efficient invasion of non-phagocytic cells by Listeria monocytogenes. Mol. Microbiol. 42 (2001) 955-965
109. de Vries F.P., Cole R., Dankert J., Frosch M., and van Putten J.P. Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol. Microbiol. 27 (1998) 1203-1212
110. Virji M., Watt S.M., Barker S., Makepeace K., and Doyonnas R. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 22 (1996) 929-939
111. Malaviya R., Ikeda T., Ross E., and Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381 (1996) 77-80
112. Parkhill J., Wren B.W., Thomson N.R., Titball R.W., Holden M.T., Prentice M.B., Sebaihia M., James K.D., Churcher C., Mungall K.L., Baker S., Basham D., Bentley S.D., Brooks K., Cerdeno-Tarraga A.M., Chillingworth T., Cronin A., Davies R.M., Davis P., Dougan G., Feltwell T., Hamlin N., Holroyd S., Jagels K., Karlyshev A.V., Leather S., Moule S., Oyston P.C., Quail M., Rutherford K., Simmonds M., Skelton J., Stevens K., Whitehead S., and Barrell B.G. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413 (2001) 523-527
113. Chain P.S., Carniel E., Larimer F.W., Lamerdin J., Stoutland P.O., Regala W.M., Georgescu A.M., Vergez L.M., Land M.L., Motin V.L., Brubaker R.R., Fowler J., Hinnebusch J., Marceau M., Medigue C., Simonet M., Chenal-Francisque V., Souza B., Dacheux D., Elliott J.M., Derbise A., Hauser L.J., and Garcia E. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13826-13831
114. Fredriksson-Ahomaa M., Stolle A., and Korkeala H. Molecular epidemiology of Yersinia enterocolitica infections. FEMS Immunol. Med. Microbiol. 47 (2006) 315-329
115. Kogelberg H., and Feizi T. New structural insights into lectin-type proteins of the immune system. Curr. Opin. Struct. Biol. 11 (2001) 635-643
116. Glaser P., Frangeul L., Buchrieser C., Rusniok C., Amend A., Baquero F., Berche P., Bloecker H., Brandt P., Chakraborty T., Charbit A., Chetouani F., Couve E., de Daruvar A., Dehoux P., Domann E., Dominguez-Bernal G., Duchaud E., Durant L., Dussurget O., Entian K.D., Fsihi H., Garcia-del Portillo F., Garrido P., Gautier L., Goebel W., Gomez-Lopez N., Hain T., Hauf J., Jackson D., Jones L.M., Kaerst U., Kreft J., Kuhn M., Kunst F., Kurapkat G., Madueno E., Maitournam A., Vicente J.M., Ng E., Nedjari H., Nordsiek G., Novella S., de Pablos B., Perez-Diaz J.C., Purcell R., Remmel B., Rose M., Schlueter T., Simoes N., Tierrez A., Vazquez-Boland J.A., Voss H., Wehland J., and Cossart P. Comparative genomics of Listeria species. Science 294 (2001) 849-852
117. Seveau S., Pizarro-Cerda J., and Cossart P. Molecular mechanisms exploited by Listeria monocytogenes during host cell invasion. Microbes Infect. 9 (2007) 1167-1175
118. Lecuit M., Ohayon H., Braun L., Mengaud J., and Cossart P. Internalin of Listeria monocytogenes with an intact leucine-rich repeat region is sufficient to promote internalization. Infect. Immun. 65 (1997) 5309-5319
119. Lecuit M., Dramsi S., Gottardi C., Fedor-Chaiken M., Gumbiner B., and Cossart P. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. Embo J. 18 (1999) 3956-3963
120. Carlsson F., and Brown E.J. Actin-based motility of intracellular bacteria, and polarized surface distribution of the bacterial effector molecules. J. Cell. Physiol. 209 (2006) 288-296
121. Lecuit M. Human listeriosis and animal models. Microbes Infect. 9 (2007) 1216-1225
122. Vazquez-Boland J.A., Kuhn M., Berche P., Chakraborty T., Dominguez-Bernal G., Goebel W., Gonzalez-Zorn B., Wehland J., and Kreft J. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev. 14 (2001) 584-640
123. Howell G.J., Holloway Z.G., Cobbold C., Monaco A.P., and Ponnambalam S. Cell biology of membrane trafficking in human disease. Int. Rev. Cytol. 252 (2006) 1-69
124. Munter S., Way M., and Frischknecht F. Signaling during pathogen infection. Sci STKE 2006 (2006) re5
125. Young G.M., Schmiel D.H., and Miller V.L. A new pathway for the secretion of virulence factors by bacteria: the flagellar export apparatus functions as a protein-secretion system. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 6456-6461
126. Holden D.W. Trafficking of the Salmonella vacuole in macrophages. Traffic 3 (2002) 161-169
127. Meresse S., Steele-Mortimer O., Finlay B.B., and Gorvel J.P. The rab7 GTPase controls the maturation of Salmonella typhimurium-containing vacuoles in HeLa cells. Embo J. 18 (1999) 4394-4403
128. Kim D.W., Lenzen G., Page A.L., Legrain P., Sansonetti P.J., and Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14046-14051
129. Zhang Y., Higashide W.M., McCormick B.A., Chen J., and Zhou D. The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase. Mol. Microbiol. 62 (2006) 786-793
130. Ogawa M., Yoshimori T., Suzuki T., Sagara H., Mizushima N., and Sasakawa C. Escape of intracellular Shigella from autophagy. Science 307 (2005) 727-731
131. Paton A.W., Beddoe T., Thorpe C.M., Whisstock J.C., Wilce M.C., Rossjohn J., Talbot U.M., and Paton J.C. AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 443 (2006) 548-552
132. Shao F., Merritt P.M., Bao Z., Innes R.W., and Dixon J.E. A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 109 (2002) 575-588
133. Glasser A.L., Boudeau J., Barnich N., Perruchot M.H., Colombel J.F., and Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69 (2001) 5529-5537
134. O'Kane C.M., Boyle J.J., Horncastle D.E., Elkington P.T., and Friedland J.S. Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages. J. Immunol. 178 (2007) 3767-3776
135. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., and Barrell B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
136. Schnupf P., and Portnoy D.A. Listeriolysin O: a phagosome-specific lysin. Microbes Infect. 9 (2007) 1176-1187
137. Kayal S., and Charbit A. Listeriolysin O: a key protein of Listeria monocytogenes with multiple functions. FEMS Microbiol. Rev. 30 (2006) 514-529
138. Gekara N.O., and Weiss S. Lipid rafts clustering and signalling by listeriolysin O. Biochem. Soc. Trans. 32 (2004) 712-714
139. Mills K.H. Immunity to Bordetella pertussis. Microbes Infect. 3 (2001) 655-677
140. Edwards J.A., Groathouse N.A., and Boitano S. Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A. Infect. Immun. 73 (2005) 3618-3626
141. El-Azami-El-Idrissi M., Bauche C., Loucka J., Osicka R., Sebo P., Ladant D., and Leclerc C. Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: role of toxin acylation and identification of the main integrin interaction domain. J. Biol. Chem. 278 (2003) 38514-38521
142. Guermonprez P., Khelef N., Blouin E., Rieu P., Ricciardi-Castagnoli P., Guiso N., Ladant D., and Leclerc C. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J. Exp. Med. 193 (2001) 1035-1044
143. Chien M., Morozova I., Shi S., Sheng H., Chen J., Gomez S.M., Asamani G., Hill K., Nuara J., Feder M., Rineer J., Greenberg J.J., Steshenko V., Park S.H., Zhao B., Teplitskaya E., Edwards J.R., Pampou S., Georghiou A., Chou I.C., Iannuccilli W., Ulz M.E., Kim D.H., Geringer-Sameth A., Goldsberry C., Morozov P., Fischer S.G., Segal G., Qu X., Rzhetsky A., Zhang P., Cayanis E., De Jong P.J., Ju J., Kalachikov S., Shuman H.A., and Russo J.J. The genomic sequence of the accidental pathogen Legionella pneumophila. Science 305 (2004) 1966-1968
144. Swanson M.S., and Hammer B.K. Legionella pneumophila pathogesesis: a fateful journey from amoebae to macrophages. Annu. Rev. Microbiol. 54 (2000) 567-613
145. Cazalet C., Rusniok C., Bruggemann H., Zidane N., Magnier A., Ma L., Tichit M., Jarraud S., Bouchier C., Vandenesch F., Kunst F., Etienne J., Glaser P., and Buchrieser C. Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity. Nat. Genet. 36 (2004) 1165-1173
146. Lencer W.I., de Almeida J.B., Moe S., Stow J.L., Ausiello D.A., and Madara J.L. Entry of cholera toxin into polarized human intestinal epithelial cells. Identification of an early brefeldin A sensitive event required for A1-peptide generation. J. Clin. Invest. 92 (1993) 2941-2951
147. Fasano A., Baudry B., Pumplin D.W., Wasserman S.S., Tall B.D., Ketley J.M., and Kaper J.B. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 5242-5246
148. Menard L.P., and Dubreuil J.D. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 (EAST1): a new toxin with an old twist. Crit. Rev. Microbiol. 28 (2002) 43-60
149. Sato T., and Shimonishi Y. Structural features of Escherichia coli heat-stable enterotoxin that activates membrane-associated guanylyl cyclase. J. Pept. Res. 63 (2004) 200-206
150. Turk B.E. Manipulation of host signalling pathways by anthrax toxins. Biochem. J. 402 (2007) 405-417
151. Inoue K., Sobhany M., Transue T.R., Oguma K., Pedersen L.C., and Negishi M. Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum. Microbiology 149 (2003) 3361-3370
152. Maksymowych A.B., Reinhard M., Malizio C.J., Goodnough M.C., Johnson E.A., and Simpson L.L. Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade. Infect. Immun. 67 (1999) 4708-4712
153. Dawson R.M., Alderton M.R., Wells D., and Hartley P.G. Monovalent and polyvalent carbohydrate inhibitors of ricin binding to a model of the cell-surface receptor. J. Appl. Toxicol. 26 (2006) 247-252
154. Fischer A., and Montal M. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10447-10452
155. FitzGerald D.J., Kreitman R., Wilson W., Squires D., and Pastan I. Recombinant immunotoxins for treating cancer. Int. J. Med. Microbiol. 293 (2004) 577-582
156. Zhang C.G., Chromy B.A., and McCutchen-Maloney S.L. Host-pathogen interactions: a proteomic view. Expert Rev. Proteomics 2 (2005) 187-202
157. Worthington Z.E., and Carbonetti N.H. Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation. Infect. Immun. 75 (2007) 2946-2953
158. Schnupf P., Zhou J., Varshavsky A., and Portnoy D.A. Listeriolysin O secreted by Listeria monocytogenes into the host cell cytosol is degraded by the N-end rule pathway. Infect. Immun. 189 (2007) 5135-51347
159. Hopkins A.M., Walsh S.V., Verkade P., Boquet P., and Nusrat A. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J. Cell Sci. 116 (2003) 725-742
160. Siccardi D., Turner J.R., and Mrsny R.J. Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease. Adv. Drug Deliv. Rev. 57 (2005) 219-235
161. Yang L., Thomas M., Woodhouse A., Martin D., Fraser J.D., and Proft T. Involvement of streptococcal mitogenic exotoxin Z in streptococcal toxic shock syndrome. J. Clin. Microbiol. 43 (2005) 3570-3573
162. van Gessel Y.A., Mani S., Bi S., Hammamieh R., Shupp J.W., Das R., Coleman G.D., and Jett M. Functional piglet model for the clinical syndrome and postmortem findings induced by staphylococcal enterotoxin B. Exp. Biol. Med. (Maywood) 229 (2004) 1061-1071
163. Maresca M., Dumay E., Fantini J., and Caporiccio B. Selective transport of staphylococcal enterotoxin A through in vitro generated human M cells. Microbes Infect. 9 (2007) 1507-1510
164. Maksymowych A.B., and Simpson L.L. Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells. J. Biol. Chem. 273 (1998) 21950-21957
165. Lencer W.I., Moe S., Rufo P.A., and Madara J.L. Transcytosis of cholera toxin subunits across model human intestinal epithelia. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 10094-10098
166. Chinnapen D.J., Chinnapen H., Saslowsky D., and Lencer W.I. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol. Lett. 266 (2007) 129-137
167. Merritt E.A., and Hol W.G. AB5 toxins. Curr. Opin. Struct. Biol. 5 (1995) 165-171
168. Ketley J.M. Pathogenesis of enteric infection by Campylobacter. Microbiology 143 Pt 1 (1997) 5-21
169. Rossetto O., and Montecucco C. Peculiar binding of botulinum neurotoxins. ACS Chem. Biol. 2 (2007) 96-98
170. Schiavo G., Demel R., and Montecucco C. On the role of polysialoglycosphingolipids as tetanus toxin receptors. A study with lipid monolayers. Eur. J. Biochem. 199 (1991) 705-711
171. Smith D.C., Lord J.M., Roberts L.M., and Johannes L. Glycosphingolipids as toxin receptors. Semin. Cell Dev. Biol. 15 (2004) 397-408
172. Lian T., and Ho R.J. Cholera toxin B-mediated targeting of lipid vesicles containing ganglioside GM1 to mucosal epithelial cells. Pharm. Res. 14 (1997) 1309-1315
173. Beauregard K.E., Wimer-Mackin S., Collier R.J., and Lencer W.I. Anthrax toxin entry into polarized epithelial cells. Infect. Immun. 67 (1999) 3026-3030
174. Wei W., Lu Q., Chaudry G.J., Leppla S.H., and Cohen S.N. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell 124 (2006) 1141-1154
175. Kounnas M.Z., Morris R.E., Thompson M.R., FitzGerald D.J., Strickland D.K., and Saelinger C.B. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267 (1992) 12420-12423
176. Pastrana D.V., Hanson A.J., Knisely J., Bu G., and Fitzgerald D.J. LRP 1 B functions as a receptor for Pseudomonas exotoxin. Biochim. Biophys. Acta 1741 (2005) 234-239
177. Spooner R.A., Smith D.C., Easton A.J., Roberts L.M., and Lord J.M. Retrograde transport pathways utilised by viruses and protein toxins. Virol. J. 3 (2006) 26
178. Wolf Z., Orso E., Werner T., Klunemann H.H., and Schmitz G. Monocyte cholesterol homeostasis correlates with the presence of detergent resistant membrane microdomains. Cytometry A 71 (2007) 486-494
179. Hamad A.R., Marrack P., and Kappler J.W. Transcytosis of staphylococcal superantigen toxins. J. Exp. Med. 185 (1997) 1447-1454
180. Hurley B.P., Jacewicz M., Thorpe C.M., Lincicome L.L., King A.J., Keusch G.T., and Acheson D.W. Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect. Immun. 67 (1999) 6670-6677
181. Hurley B.P., Thorpe C.M., and Acheson D.W. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect. Immun. 69 (2001) 6148-6155
182. Philpott D.J., Ackerley C.A., Kiliaan A.J., Karmali M.A., Perdue M.H., and Sherman P.M. Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am. J. Physiol. 273 (1997) G1349-G1358
183. Hoey D.E., Sharp L., Currie C., Lingwood C.A., Gally D.L., and Smith D.G. Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell. Microbiol. 5 (2003) 85-97
184. Skretting G., Torgersen M.L., van Deurs B., and Sandvig K. Endocytic mechanisms responsible for uptake of GPI-linked diphtheria toxin receptor. J. Cell Sci. 112 Pt 22 (1999) 3899-3909
185. Smith D.C., Spooner R.A., Watson P.D., Murray J.L., Hodge T.W., Amessou M., Johannes L., Lord J.M., and Roberts L.M. Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic 7 (2006) 379-393
186. Reineke J., Tenzer S., Rupnik M., Koschinski A., Hasselmayer O., Schrattenholz A., Schild H., and von Eichel-Streiber C. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446 (2007) 415-419
187. Matsuzawa T., Fukui A., Kashimoto T., Nagao K., Oka K., Miyake M., and Horiguchi Y. Bordetella dermonecrotic toxin undergoes proteolytic processing to be translocated from a dynamin-related endosome into the cytoplasm in an acidification-independent manner. J. Biol. Chem. 279 (2004) 2866-2872
188. Masuda M., Minami M., Shime H., Matsuzawa T., and Horiguchi Y. In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin. Infect. Immun. 70 (2002) 998-1001
189. Olivier V., Haines III G.K., Tan Y., and Satchell K.J. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains. Infect. Immun. 75 (2007) 5035-5042
190. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat. Rev., Cancer 6 (2006) 688-701
191. Weber J.R., and Tuomanen E.I. Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J. Neuroimmunol. 184 (2007) 45-52